product name Clorprenaline HCl
Description: Clorprenaline HCl is a β2-receptor agonist, it has a significant expansion of the bronchial effect. The linear ranges 8.0-1.6 ×103 ng/mL for Clorprenaline in a single chromatographic run, the detection limits 3.0 ng/mL for Clorprenaline. Clorprenaline is a bronchodilator that has been separated by CE based on affinity-interaction or with charged CD-CZE sulfobuthylether (SBE)-β-CD or β-CD-phosphate with resolution greater than 1.2.
References: J Pharm Biomed Anal. 2005 Jun 1;38(1):166-72.
250.16
Formula
C11H16ClNO.HCl
CAS No.
6933-90-0
Storage
-20℃ for 3 years in powder form
-80℃ for 2 years in solvent
Solubility (In vitro)
DMSO: 50 mg/mL (199.8 mM)
Water: 50 mg/mL (199.8 mM)
Ethanol: 50 mg/mL (199.8 mM)
Solubility (In vivo)
Synonyms
NSC 334693
other peoduct :References PubMed ID：:http://www.ncbi.nlm.nih.gov/pubmed/19398371
| In Vitro |
In vitro activity: The linear ranges 8.0-1.6 ×103 ng/mL for Clorprenaline in a single chromatographic run, the detection limits 3.0 ng/mL for Clorprenaline. Clorprenaline is a bronchodilator that has been separated by CE based on affinity-interaction or with charged CD-CZE sulfobuthylether (SBE)-β-CD or β-CD-phosphate with resolution greater than 1.2. Clorprenaline is separated in optimum condition of 60 mM HP-β-CD. Clorprenaline hydrochloride (a), bromhexine hydrochloride (b) and decloxizine hydrochloride (c) are three main components in clorprenaline compound tablet. Kinase Assay: Cell Assay: |
|---|---|
| In Vivo | |
| Animal model | |
| Formulation & Dosage | |
| References | J Pharm Biomed Anal. 2005 Jun 1;38(1):166-72. |
Related Posts
product name Clorprenaline HCl
Description: Clorprenaline HCl is a β2-receptor agonist, it has a significant expansion of the bronchial effect. The linear ranges 8.0-1.6 ×103 ng/mL for Clorprenaline in a single chromatographic run, the detection limits 3.0 ng/mL for Clorprenaline. Clorprenaline is a bronchodilator that has been separated by CE based on affinity-interaction or with charged CD-CZE sulfobuthylether (SBE)-β-CD or β-CD-phosphate with resolution greater than 1.2.
References: J Pharm Biomed Anal. 2005 Jun 1;38(1):166-72.
250.16
Formula
C11H16ClNO.HCl
CAS No.
6933-90-0
Storage
-20℃ for 3 years in powder form
-80℃ for 2 years in solvent
Solubility (In vitro)
DMSO: 50 mg/mL (199.8 mM)
Water: 50 mg/mL (199.8 mM)
Ethanol: 50 mg/mL (199.8 mM)
Solubility (In vivo)
Synonyms
NSC 334693
other peoduct :References PubMed ID：:http://www.ncbi.nlm.nih.gov/pubmed/19398371
| In Vitro |
In vitro activity: The linear ranges 8.0-1.6 ×103 ng/mL for Clorprenaline in a single chromatographic run, the detection limits 3.0 ng/mL for Clorprenaline. Clorprenaline is a bronchodilator that has been separated by CE based on affinity-interaction or with charged CD-CZE sulfobuthylether (SBE)-β-CD or β-CD-phosphate with resolution greater than 1.2. Clorprenaline is separated in optimum condition of 60 mM HP-β-CD. Clorprenaline hydrochloride (a), bromhexine hydrochloride (b) and decloxizine hydrochloride (c) are three main components in clorprenaline compound tablet. Kinase Assay: Cell Assay: |
|---|---|
| In Vivo | |
| Animal model | |
| Formulation & Dosage | |
| References | J Pharm Biomed Anal. 2005 Jun 1;38(1):166-72. |